Beyond hematologic malignancies, TP53 is the second most frequently mutated gene in colorectal cancer (CRC), occurring in approximately 60% of patients with CRC, and is strongly associated with advanced disease stages and poor prognosis10. Here, TP53 is linked to colorectal carcinoma.